We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$600M
AUM Growth
+$17.4M
Cap. Flow
-$111M
Cap. Flow %
-18.53%
Top 10 Hldgs %
46.91%
Holding
88
New
3
Increased
52
Reduced
18
Closed
6

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$1.21M
2
COIN icon
Coinbase
COIN
+$768K
3
BMY icon
Bristol-Myers Squibb
BMY
+$520K
4
VZ icon
Verizon
VZ
+$379K
5
LMT icon
Lockheed Martin
LMT
+$372K

Sector Composition

Rank Sector Weight
1 Healthcare 33.14%
2 Technology 22.3%
3 Financials 10.98%
4 Consumer Discretionary 10.02%
5 Communication Services 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$53.7M 8.95%
302,522
+315
+0.1% +$49.8K
ISRG icon
2
Intuitive Surgical
ISRG
$121B
$49.7M 8.29%
138,368
-290,995
-68% -$100M
IDXX icon
3
Idexx Laboratories
IDXX
$42.9B
$28.7M 4.79%
43,639
-3,207
-7% -$2.01M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$3.91T
$28.3M 4.71%
195,040
-1,140
-0.6% -$164K
ABMD
5
DELISTED
Abiomed Inc
ABMD
$27.9M 4.65%
77,703
-5,448
-7% -$1.84M
MA icon
6
Mastercard
MA
$477B
$26.9M 4.49%
74,997
-1,905
-2% -$659K
AMZN icon
7
Amazon
AMZN
$2.5T
$17.2M 2.87%
103,460
+280
+0.3% +$47.9K
XYZ
8
Block Inc
XYZ
$45.9B
$17.2M 2.87%
106,606
+216
+0.2% +$46.8K
ADBE icon
9
Adobe
ADBE
$89.5B
$16.3M 2.71%
28,690
-78
-0.3% -$48.8K
EW icon
10
Edwards Lifesciences
EW
$47.6B
$15.5M 2.58%
119,483
-3,615
-3% -$422K
MSFT icon
11
Microsoft
MSFT
$2.84T
$15.4M 2.56%
45,648
-510
-1% -$165K
LOW icon
12
Lowe's Companies
LOW
$116B
$15M 2.5%
58,012
-30
-0.1% -$7.13K
ILMN icon
13
Illumina
ILMN
$29.4B
$14.9M 2.48%
40,134
-1,871
-4% -$709K
SIVB
14
DELISTED
SVB Financial Group
SIVB
$14.3M 2.38%
21,078
-133
-0.6% -$93.7K
JPM icon
15
JPMorgan Chase
JPM
$939B
$13.7M 2.29%
86,749
-225
-0.3% -$37K
PG icon
16
Procter & Gamble
PG
$343B
$11.1M 1.85%
67,722
+661
+1% +$98.1K
TEAM icon
17
Atlassian
TEAM
$22B
$10.7M 1.78%
28,005
-139
-0.5% -$55.9K
NVDA icon
18
NVIDIA
NVDA
$5.01T
$10.2M 1.71%
348,300
+780
+0.2% +$21.5K
ABBV icon
19
AbbVie
ABBV
$458B
$9.76M 1.63%
72,097
+2,233
+3% +$264K
MCD icon
20
McDonald's
MCD
$188B
$9.25M 1.54%
34,327
+685
+2% +$173K
XOM icon
21
ExxonMobil
XOM
$651B
$9.21M 1.54%
148,459
+836
+0.6% +$52.3K
EXAS
22
DELISTED
Exact Sciences
EXAS
$8.45M 1.41%
108,522
-4,659
-4% -$411K
JNJ icon
23
Johnson & Johnson
JNJ
$635B
$7.89M 1.31%
45,831
+1,670
+4% +$273K
SPG icon
24
Simon Property Group
SPG
$74.5B
$7.87M 1.31%
49,265
+680
+1% +$104K
TFC icon
25
Truist Financial
TFC
$63.2B
$7.57M 1.26%
128,285
+5,196
+4% +$317K

Similar funds

Biondo Investment Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Biondo Investment Advisors held 88 positions worth $600M, up 3% from $583M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Biondo Investment Advisors withdrew a net $111M in Q4 2021, closing 6 positions and reducing 18 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

Against the trend, Biondo Investment Advisors opened a new position in Unity worth $1.14M.

  • Biondo Investment Advisors's largest Q4 2021 buy was Unity: 7,945 shares worth $1.14M.
  • Biondo Investment Advisors added most to Bristol-Myers Squibb in Q4 2021, an estimated $520K increase.
  • Biondo Investment Advisors's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $100M.
  • Biondo Investment Advisors fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $10.5M.
  • Biondo Investment Advisors's ten largest holdings make up 47% of its $600M portfolio in Q4 2021.
  • Biondo Investment Advisors opened 3 new positions and closed 6 in Q4 2021.
  • Biondo Investment Advisors's portfolio value rose 3% quarter-over-quarter to $600M.

Based on Biondo Investment Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.